How much did Aulos Bioscience, Inc. raise?

Aulos Bioscience, Inc. raised $15 Million in a funding round on November 16, 2020.

Who are the decision-makers at Aulos Bioscience, Inc?

Fundz holds 1 contact at Aulos Bioscience, Inc., including the Director. Names and contact details are shown to Fundz members.

Aulos Bioscience, Inc. reported raising $15 Million in an initial SEC Form D filing, from an offering of $40 Million

PRIVATENov 16, 2020$15M of $40M raised

Amount Raised

$15 Million

$15 Million sold, per SEC Form D (first sale Nov 16, 2020)

Round Type

Venture

LarkspurBiotechnology

Quick answer

Aulos Bioscience, Inc. raised $15 Million in a funding round, dated November 16, 2020. Aulos Bioscience, Inc. is based in Larkspur, California, United States.

How much did Aulos Bioscience, Inc. raise?: Aulos Bioscience, Inc. raised $15 Million in a funding round on November 16, 2020.
What does Aulos Bioscience, Inc. do?: Aulos Bioscience is an immuno-oncology company revolutionizing cancer patient care through best-in-class IL-2 therapeutics computationally designed to exquisitely direct patients’ own immune systems towards killing..
Where is Aulos Bioscience, Inc. based and how big is it?: Aulos Bioscience, Inc. is based in Larkspur, California, United States.
Who are the decision-makers at Aulos Bioscience, Inc?: Fundz holds 1 contact at Aulos Bioscience, Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Aulos Bioscience, Inc. that raised within 45 days of this round, from Fundz verified event records.

CYTIMMUNE SCIENCES INC raised $998K (Seed) on December 31, 2020.
LeafWorks Inc. raised $679K (Seed) on December 30, 2020.
NUTRALIFE BIOSCIENCES, INC raised $25K (Seed) on December 30, 2020.
Celtic Renewables raised $2.2M on December 30, 2020.
Akston raised $3.4M (Seed) on December 30, 2020.
Peptilogics raised $36M on December 30, 2020.

Who to call at Aulos Bioscience, Inc., and when

A new round usually means Aulos Bioscience, Inc. is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Aulos Bioscience, Inc. raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Aulos Bioscience, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aulos Bioscience, Inc.. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aulos Bioscience, Inc.

Location

700 LARKSPUR LANDING CIR

Larkspur, California, United States

About

Aulos Bioscience is an immuno-oncology company revolutionizing cancer patient care through best-in-class IL-2 therapeutics computationally designed to exquisitely direct patients’ own immune systems towards killing tumor cells. Matching world-class machine learning from founder and partner Biolojic Design with an in-depth understanding of the immune system, Aulos’ initial clinical candidate, AU-007, has been designed to harness the power of a patient’s own IL-2 to induce tumor killing while limiting the immunosuppression and toxicities typically associated with this validated class of therapeutics. AU-007 has the potential to become a best-in-class treatment for solid tumors. The company was founded by Biolojic Design and ATP with $40M in Series A funding from ATP and is led by pioneers in the field of artificial intelligence, antibody development and cancer immunotherapies. For more information, visit aulosbio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aulos Bioscience, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Verified contactsMicah P., Director hiddenSee plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for Aulos Bioscience, Inc.'s next move

See what Strategic adds

Aulos Bioscience, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.